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In an attempt to investigate the prognosis of malignant tumors of the kidney, a follow-up study was made in 29 cases of hypernephroma and 11 cases of carcinoma of the renal pelvis over a period ranging from 3 to 9 years, and the following results were obtained.
1) The 3 and 5-year survival rates of hypernephroma treated by nephrectomy were 39% (9/23) and 30% (4/13) respectively, while those of pelvic tumor were 33% (3/9) and 33% (2/6).
2) In cases of these malignant tumors the prognosis was generally poor when: a) the patients received medical examinations late after the first symptoms, b) the tumor had attained a large size already at the first examination, c) extirpated tumor was also large, d) extracapsular spread had already occurred, and e) there were demonstrable metastatic lesions.
Renal tumors are rather rare, and not a few patients are found inoperable since they are apt to come for consultation in considerably advanced stages of the disease.
For these reasons, the prognosis after surgical treatments of renal neoplasms has been discussed only in a limited number of reports.
In the present paper the results of a follow-up study made on patients with hypernephroma or carcinoma of the renal pelvis for periods of 3 or 5 years are described.
MATERIALS AND RESULTS
This paper presents the result obtained on a total of 40 adult patients with malignant renal neoplasms; hypernephroma or pelvic carcinoma. Of these there were 6 cases of hypernephroma (including 4 cases of exploratory laparotomy and 2 non-operative cases) and 2 cases of pelvic tumor (one of exploratory laparotomy and one non-operative) where the disease was found to be too advanced for ne phrectomy. These non-nephrectomized patients will be discussed separately.
Results in nephrectomy cases
The survival time after discharge from the hospital in the group of 32 patients having received nephrectomy is shown in Table 1 . As is apparent from the table, the 3-year survival rate for this group was 9/23 (39%) for hypernephroma and 3/9 (33%) for pelvic tumor, while the 5-year survival rate was 4/13 (30%) for hypernephroma and 2/6 (33%) for pelvic tumor.
Age of onset. The age at the onset of the disease is listed in Table 2 . It is obvious that the peak of frequency is found at 51 to 60 years for hypernephroma, and 61 to 70 years for pelvic tumor. Fig. 1 illustrates the relation between the age of onset and the survival time. In the hypernephroma group 6 of 10 cases under 50 years of age, but only 3 of 13 above that age are alive. Of the patients with pelvic tumor, 2 patients under 50 years of age died within a year, while 3 of those above 51 years of age are still alive.
Period from the onset to the first visit. The period from the onset of symptoms to the first visit is shown in Table 3 . The average was 18 months for patients with hypernephroma and 11 months for those with pelvic tumor. The relation of this period to the survival time is presented in Fig. 2 . It can be seen that the •› Survival •oe Death survival rate was higher for those who came for consultation within a year of the first symptoms.
Tumor size. The size of tumor detected at the first examination is given in Findings at operation. Table 5 summarized the extent of tumor discovered at operation. The relation between the degree of tumor extension and the survival time is shown in Fig. 4 . A distinct difference in the survival time between hypernephroma cases of lesions confined within the renal capsule and those with extracapsular tumor spread; that is, 6 out of 11 are surviving in the former, whereas only 3 out of 12 in the latter. Of 4 patients in whom daughter nodes were demon strable in the renal substance or pelvis, 3 died within 6 months, and only one survived 5 years. In one case where infiltration had reached adjacent muscles, death occurred within 6 months. However, in another case the patient survived 3 years in spite of involvement of the liver capsule at the time of operation. On the other hand, all of 7 patients with tumor embolism of the renal vein died mostly within 6 months.
As for pelvic tumors, no difference in the survival time was noticeable between cases of intrarenal tumor and those of extracapsular extension; that is, 2 of the former 5 cases are still alive, and one of the latter 4 cases has survived more than 5 years.
Of 5 cases where the ureter was found to be invaded by the tumor, only one is alive. Both the afore-mentioned patient having muscular infiltration and the one •› Survival •oe Death Metastases of the pelvic tumor were seen in all of 4 cases, 3 preoperatively and 1 after discharge. These patients all died within 4 years.
Histological findings. In the cases of hypernephroma the tumors were histo logically of clear cell type in 13 cases, of granular cell type in 1 and of mixed type in the other 9. The relation between the histological findings and the survival time is illustrated in Fig. 6 . It is evident that there is no substantial difference in the survival time among the 3 types. Of the 13 cases of clear-cell hypernephroma, 6 are still alive and the other 7 died within 2 years, while the one case of granular cell hypernephroma has survived 4 years and 5 months. Of the 9 cases of mixed type carcinoma, 2 are still alive and the others died in less than 3 years.
Out of 9 cases of pelvic tumors 8 had histologically transitional-cell carcinoma while in the other one the histological pattern was characterized by partial hyper keratosis suggestive of squamous cell carcinoma. In the latter case the patient died within a year after nephrectomy (Fig. 6) . operation or after discharge metastasis detected after discharge from the hospital. Accessory therapy. As indicated in Table 8 , chemotherapy (Mitomycin, Toyo mycin), and radiotherapy by cobalt or x-ray were used in combination with surgical treatment. In all the cases of these combined therapies the disease had already considerably advanced at the time of treatments. 
Results of non-nephrectomy cases
As indicated in Table 9 , the cases where nephrectomy was not feasible included 6 of hypernephroma and 2 of pelvic tumor. The outcome of the patients were fatal.
DISCUSSION
The prognosis in renal neoplasms has been generally considered to depend largely upon the following three major factors; 1) the degree of topological extension of the lesion; 2) the degree of malignancy from the viewpoint of the histological pattern, and 3) therapeutic measures. a) Intracapsular; the pseudo-capsule of the tumor is intact. b) Intrarenal, extracapsular; the pseudo-capsule is broken or absent. In stages a) and b) neither veins nor lymphatics are invaded. c) Periorganic; there is no pseudo-capsule or only a trace of it, and the tumor has not only given rise to intrarenal metastasis but also spread into and adhered to the perirenal tissue. Veins and adjacent lymphatics are invaded. d) Systemic involvement; distant metastases are demonstrable, though local findings are similar to those at stage c). He reported that a distinct correlation was noticeable between these stages and the predictable development of the disease.
In our grading of the development of renal neoplasms, 'intracapsular invasion' corresponds to Flocks and Kadesky's stage 1) and Petkovic's stage a), and our ' extracapsular invasion', to their stage 2) and stage b), and some differences in prognosis are noted between Flocks and Kadesky's and Petkovic's classifications.
According to Petkovic's classification, tumor embolism is to be included in c). Concerning the difference in prognosis between patients with and without tumor embolism, McDonald and Priestley3 reported that the 5-year survival rate in the former was 29%, while that in the latter 55.4%. Similar results were reported by Riches4 and Arner et al. 5 Our own result also indicated that none of the patients with tumor embolism of the renal veins survived more than 3 years.
As for pelvic tumors, Riches4 stated that prognosis in cases of the papillary tumor of the renal pelvis was somewhat more favorable for patients with the lesion confined in the urinary tract than for those with the lesion spreading outside the tract.
In our present study, however, no definite difference was noticeable, probably because of the small number of our examined cases.
As for the relation of the weight or size of the tumor to prognosis, Bixler et al.6 divided the patients with parenchymal tumor of the kidney into 2 groups accord ing to the weight of the affected kidney, below 500g and 500 to 1,000g. They reported that the fatality in the first year following nephrectomy was 20% for the former group, whereas it was as high as 40% for the latter. Arner et al.5 also described that the 5-year survival rate in a group of patients with parenchymal tumor of less than 7cm in diameter was 69.4%, while that of 7 to 15cm in diameter was 39.6%. Besides, there have been a number of similar reports on this problem. So far as our present study is concerned, the weight of extirpated kidneys contain ing parenchymal neoplasm averaged 470g, and that of the kidneys bearing pelvic tumor averaged 279g. And the difference in prognosis was quite evident according to whether the weight of extirpated kidney was above or below the average.
The presence of distant metastases makes of course the prognosis worse. Flocks and Kadesky1 reported that the 5 and 10-year survival rates of the patients with metastases of hypernephroma were 3.5% and 1.3%, respectively. Our results revealed that only one of 11 cases of hypernephroma with demonstrable metastases survived three and a half years, while none of the patients with pelvic tumor with systemic involvement survived more than 5 years.
The correlation between the histological findings and prognosis has been intensely debated. Hypernephroma is usually divided into the following 3 types from the histological point of view; clear-cell, granular-cell, and mixed types. Riches4 stressed the difference in prognosis among these 3 types and not a few authors have agreed with him. On the other hand, there are some reports stating that histological features, whether of clear-cell or of granular-cell, have no distinct bearing upon the prognosis. For instance, Muto7 is of the opinion that clinical symptoms are quite the same in adult patients with hypernephroma regardless of whether the tumor is histologically of clear-cell or granular-cell type and he has pointed out that hypernephroma is rarely composed of clear cells only, and usually contains more or less granular cell elements too, and further that these two types of tumor cell are entirely the same in their origin, differing from each other only in appearance at different stages of development. In our present study, histological diagnosis could be established in a total of 26 cases including those of exploratory laparotomy, and no significant difference in prognosis was notable between the two histological patterns. Only one of the patients having granular-cell carcinoma survived 4 years and 5 months after nephrectomy.
On the other hand, pelvic tumors may be classified histologically into transi tional cell carcinoma and squamous cell carcinoma, and an apparent difference in prognosis is known to exist between the two types. Riches4 and Higgins8 described that they had never experienced a case of squamous cell carcinoma, in which the patient had survived more than 5 years. One patient of our series with pelvic tumor composed partially of squamous cell elements died in less than a year. A s for radiotherapy, Royce and Tormey9 stated that in renal tumors even large doses of x-ray and 60Co brought about no favorable therapeutic response but rather untoward side effects, expressing therefore a pessimistic view on the effect of such treatments. On the contrary, Riches10 and Bratherton11 found radiotherapy to be of benefit. Bratherton reported that the 3-, 5-and 10-year survival rates in a group of patients treated by nephrectomy alone averaged 38%, 29% and 27% respectively, while those of the patients who received both nephrectomy and x-ray radiation were generally higher and 44%, 43% and 33%, respectively. So far as our present study is concerned, the prognosis was not necessarily improved by concurrent radiotherapy. This is probably because our cases received radiotherapy at an advanced stage where the recurrence was inevitable, and so any negative conclusion concerning the effectiveness of x-ray radiation cannot be drawn out of our results.
The results of chemotherapy hitherto reported are also rather disappointing. Woodruff et al.,12 for instance, could observe a therapeutic response in only 30 out of 270 cases in which concomitant use of anticancer agents had been made. In our present series, the combined use of chemotherapeutic agents resulted adversely in the worsening of prognosis. This may be presumably due to the fact that chemotherapy was carried out exclusively in those cases where the disease had already much advanced.
